ASH 2020: Session 625, DSP107 Presentation
Combining CD47 Inhibition with Targeted Activation of 41BB to trigger Innate and Adaptive Anticancer Immune Responses
https://kahrbio.com/wp-content/uploads/2021/12/ASH-2020.DSP107.session-625_Oral-presentation.pdf
